| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.04 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.08 | 0.04 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.54 | 0.04 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.05 |